Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas. Summary: Breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses lasik or laser vision correction, which is a great option for those who…
Hylton Mayer, MD, Assistant Clinical Professor Yale University Department of Opthalmology, discusses capsular tension rings, plastic like device used at the time of cataract surgery to assist in…
Jonathan Sears, MD, Associate Professor of Ophthalmology, Cole Eye Institute, Cleveland Clinic, discusses retinopathy of prematurity, which affects 10-15% of the 500,000 premature infants born annually in the…
NEW YORK (Reuters Health) – For patients with cerebral ischemia, treatment with tissue plasminogen activator (TPA) is known to confer substantial benefit when given within 3 hours of…
NEW YORK (Reuters Health) – Information from previous colonoscopies may help identify low-risk polypectomy patients who are unlikely to benefit from intense surveillance, a large prospective cohort study…
NEW YORK (Reuters Health) – Findings from the Cardiovascular Health Study-Cognition Substudy suggest that angiotensin-converting enzyme (ACE) inhibitors that cross the blood-brain barrier reduce the risk of incident…
NEW YORK (Reuters Health) – A network of altered genes appears to play a key role in the pathogenesis of gliomas, according to a report in the Journal…
